The synthetic and structure-activity relationship (SAR) studies of new non-peptide GPIIb/IIIa antagonists (1a-f and 3) were conducted by replacing one amide bond of NSL-95300 (2) with an (E)-double bond or an enone group. NSL-95315 (1a) and NSL-95317 (3) showed the inhibitory activity for collagen-induced human platelet aggregation with IC50 values of 0.25 mu M and 0.21 mu M, respectively. (C) 1997 Elsevier Science Ltd.
引用
收藏
页码:2099 / 2104
页数:6
相关论文
共 17 条
[1]
Cook Nigel S., 1994, Drugs of the Future, V19, P135
[2]
Dickerson R. E., 1969, STRUCTURE ACTION PRO, P13